This site is intended for health professionals only

Sanofi pulls US rimonabant application


It comes as no surprise but Sanofi-Aventis has withdrawn its marketing application to gain approval in the USA for its obesity drug Acomplia

Be in the know
Subscribe to Hospital Pharmacy Europe newsletter and magazine